Cargando…

P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY

Detalles Bibliográficos
Autores principales: Patel, J., Keshavarz, B., Richards, N., Workman, L., Muehling, L., Murphy, D., Eschenbacher, W., Nelson, M., Platts-Mills, T., Wilson, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566842/
http://dx.doi.org/10.1016/j.anai.2021.08.116
_version_ 1784594103515742208
author Patel, J.
Keshavarz, B.
Richards, N.
Workman, L.
Muehling, L.
Murphy, D.
Eschenbacher, W.
Nelson, M.
Platts-Mills, T.
Wilson, J.
author_facet Patel, J.
Keshavarz, B.
Richards, N.
Workman, L.
Muehling, L.
Murphy, D.
Eschenbacher, W.
Nelson, M.
Platts-Mills, T.
Wilson, J.
author_sort Patel, J.
collection PubMed
description
format Online
Article
Text
id pubmed-8566842
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85668422021-11-04 P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY Patel, J. Keshavarz, B. Richards, N. Workman, L. Muehling, L. Murphy, D. Eschenbacher, W. Nelson, M. Platts-Mills, T. Wilson, J. Ann Allergy Asthma Immunol Article Published by Elsevier Inc. 2021-11 2021-11-04 /pmc/articles/PMC8566842/ http://dx.doi.org/10.1016/j.anai.2021.08.116 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Patel, J.
Keshavarz, B.
Richards, N.
Workman, L.
Muehling, L.
Murphy, D.
Eschenbacher, W.
Nelson, M.
Platts-Mills, T.
Wilson, J.
P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
title P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
title_full P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
title_fullStr P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
title_full_unstemmed P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
title_short P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
title_sort p095 levels of igg to sars-cov-2 in recipients of covid-19 vaccines: longitudinal monitoring with quantitative assay
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566842/
http://dx.doi.org/10.1016/j.anai.2021.08.116
work_keys_str_mv AT patelj p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT keshavarzb p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT richardsn p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT workmanl p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT muehlingl p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT murphyd p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT eschenbacherw p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT nelsonm p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT plattsmillst p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay
AT wilsonj p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay